Home/Pipeline/Fesoterodine (Toviaz)

Fesoterodine (Toviaz)

Overactive Bladder (OAB)

ApprovedCommercial

Key Facts

Indication
Overactive Bladder (OAB)
Phase
Approved
Status
Commercial
Company

About KYORIN Pharmaceutical

KYORIN Pharmaceutical is a mid-sized, revenue-generating Japanese pharmaceutical company with a diversified portfolio spanning prescription drugs, over-the-counter (OTC) products, and veterinary medicines. The company leverages its expertise in respiratory and urological diseases to maintain a stable revenue base from commercial products while investing in R&D for future growth. Its strategic focus includes lifecycle management of key brands and advancing its pipeline through internal research and selective partnerships.

View full company profile

Other Overactive Bladder (OAB) Drugs

DrugCompanyPhase
KRP-118KYORIN PharmaceuticalPhase 2